Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra to Prevent Immunothrombosis in Pancreatic Transplant Recipients
NCT07503834Phase 2Recruiting
- Sponsor
- CHU de Nantes
- Start
- Oct 2026
- Primary completion
- Apr 2029
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of anakinra in immunothrombosis, Pancreatic allograft rejection, sponsored by CHU de Nantes. Started Oct 2026; status: recruiting.
02
Drugs
anakinra
03
Conditions
immunothrombosisPancreatic allograft rejection
Beyond the preview
Go deeper on NCT07503834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07503834.